Advanced search
Publication Cover
OncoTargets and Therapy Volume 12, 2019 - Issue
Submit an article Journal homepage
54
Views
13
CrossRef citations to date
0
Altmetric
Original Research

The proliferation of cervical cancer is promoted by miRNA-125b through the regulation of the HMGA1

Bingmei SunDepartment of Gynaecology and Obstetrics, Linyi Central Hospital, Linyi 276400, Shandong Province, China, [email protected]
,
Ying ZhangDepartment of Gynaecology and Obstetrics, Linyi Central Hospital, Linyi 276400, Shandong Province, China, [email protected]
,
Lianxiang ZhouDepartment of Gynaecology and Obstetrics, Linyi Central Hospital, Linyi 276400, Shandong Province, China, [email protected]
,
Linin YinDepartment of Gynaecology and Obstetrics, Linyi Central Hospital, Linyi 276400, Shandong Province, China, [email protected]
,
Fei LiDepartment of Gynaecology and Obstetrics, Linyi Central Hospital, Linyi 276400, Shandong Province, China, [email protected]
,
Chao LiDepartment of Gynaecology and Obstetrics, Linyi Central Hospital, Linyi 276400, Shandong Province, China, [email protected]
&
Jiayu XiaDepartment of Gynaecology and Obstetrics, Linyi Central Hospital, Linyi 276400, Shandong Province, China, [email protected]Correspondence[email protected]
 show all
Pages 2767-2776 | Published online: 11 Apr 2019

References

  • Cervical cancer analysis reveals new mutationsCancer Discov201774344
  • AlldredgeJKTewariKSClinical trials of antiangiogenesis therapy in recurrent/persistent and metastatic cervical cancerOncologist201621557658510.1634/theoncologist.2015-033627026677
  • WuDMShiJLiuTIntegrated analysis reveals down-regulation of SPARCL1 is correlated with cervical cancer development and progressionCancer Biomark201821235536510.3233/CBM-17050129103025
  • DizonDSMackayHJThomasGMState of the science in cervical cancer: where we are today and where we need to goCancer2014120152282228810.1002/cncr.2872224737608
  • LeeYSDuttaAMicroRNAs in cancerAnnu Rev Pathol2009419922710.1146/annurev.pathol.4.110807.09222218817506
  • ShinVYChuKMMiRNA as potential biomarkers and therapeutic targets for gastric cancerWorld J Gastroenterol20142030104321043910.3748/wjg.v20.i30.1043225132759
  • XieHLiaoXChenZLncRNA MALAT1 inhibits apoptosis and promotes invasion by antagonizing miR-125b in bladder cancer cellsJ Cancer20178183803381110.7150/jca.2122829151968
  • TanakaHHazamaSIidaMmiR-125b-1 and miR-378a are predictive biomarkers for the efficacy of vaccine treatment against colorectal cancerCancer Sci2017108112229223810.1111/cas.1339028859241
  • YangLZhangXMaYAscites promotes cell migration through the repression of miR-125b in ovarian cancerOncotarget2017831510085101528881624
  • BuQYouFPanGMiR-125b inhibits anaplastic thyroid cancer cell migration and invasion by targeting PIK3CDBiomed Pharmacother20178844344810.1016/j.biopha.2016.11.09028122310
  • HeYLinJDingYA systematic study on dysregulated microRNAs in cervical cancer developmentInt J Cancer201613861312132710.1002/ijc.2961826032913
  • Granados-LopezAJRuiz-CarrilloJLServin-GonzalezLSUse of mature miRNA strand selection in miRNAs families in cervical cancer developmentInt J Mol Sci201718210.3390/ijms18020407
  • WangWTChenYQCirculating miRNAs in cancer: from detection to therapyJ Hematol Oncol201478610.1186/s13045-014-0086-025476853
  • ZhangYZhangDWangFXuDGuoYCuiWSerum miRNAs panel (miR-16-2*, miR-195, miR-2861, miR-497) as novel non-invasive biomarkers for detection of cervical cancerSci Rep201551794210.1038/srep1794226656154
  • ZhouQHanLRZhouYXLiYMiR-195 suppresses cervical cancer migration and invasion through targeting Smad3Int J Gynecol Cancer201626581782410.1097/IGC.0000000000000686
  • LiangHLuoRChenXZhaoYTanAmiR-187 inhibits the growth of cervical cancer cells by targeting FGF9Oncol Rep20173841977198410.3892/or.2017.585128849071
  • WuJGWangJJJiangXMiR-125b promotes cell migration and invasion by targeting PPP1CA-Rb signal pathways in gastric cancer, resulting in a poor prognosisGastric Cancer201518472973910.1007/s10120-014-0421-825240408
  • LiXZhengJChenLDiaoHLiuYPredictive and prognostic roles of abnormal expression of tissue miR-125b, miR-221, and miR-222 in gliomaMol Neurobiol201653157758310.1007/s12035-014-9017-x25502291
  • LiuWHuJZhouKSerum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinomaOnco Targets Ther2017103843385110.2147/OTT.S14006228814883
  • XiYLiYSTangHBHigh mobility group A1 protein acts as a new target of Notch1 signaling and regulates cell proliferation in T leukemia cellsMol Cell Biochem20133741–217318010.1007/s11010-012-1517-223229232
  • ChengHWChenYFWongJMCancer cells increase endothelial cell tube formation and survival by activating the PI3K/Akt signalling pathwayJ Exp Clin Cancer Res20173612710.1186/s13046-017-0495-328173828
  • YangCWangMHZhouJDChiQUpregulation of miR-542-3p inhibits the growth and invasion of human colon cancer cells through PI3K/AKT/survivin signalingOncol Rep20173863545355310.3892/or.2017.585129130099
  • BahramiAHasanzadehMHassanianSMThe potential value of the PI3K/Akt/mTOR Signaling pathway for assessing prognosis in cervical cancer and as a target for therapyJ Cell Biochem2017118124163416910.1002/jcb.2611828475243

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.